RGB Medical Devices specializes in medical technology, providing equipment for operating rooms, intensive care units, and home care settings. The company has been innovating in this field since 1988 and complies with total quality standards.

RGB Medical Devices

Arseus Medical Group specializes in the distribution of medical and paramedical products and aids that meet healthcare needs, focusing on both patients and care providers.

Arseus Medical Group

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.

Abiomed, Inc.

Aknamed is a hospital-focused supply chain platform that enables hospitals to simplify, optimize and monitor procurement and consumption through a cloud-based technology platform.

Aknamed

RGB Medical Devices S.A. | 517 followers on LinkedIn. RGB Medical Devices was established in 1988 as a University spin-off. Amongst the different pioneering devices manufactured by the company is the Baricontrol.  This device was designed for B.Braun Infusion pumps Manufacturer to be used in clinical operations and intensive care units.

Project Manager en RGB Medical Devices S.A.

Ricardo Nolasco Ruiz

Ingeniero Industrial - Automática y Electrónica

Javier de Teresa Alcalde

Responsable de Logística Dpto. Producción en RGB Medical Devices

Oscar Barahona Moreno

Administrador en RGB Medical Devices S.A.

Esperanza Nolasco Bethencourt

RGB Medical Devices S.A.

Clean and complete patient monitoring in the OR, without overloading one screen. - Ventilation - Vital Signs - Special parameters: + Neuromuscular Blockade + Depth of Anesthesia + Pain management

MEDICA - Leading International Trade Fair , as the leading annual exhibition of advanced medical technologies, took place from 13-16 November 2023 in Düsseldorf, Germany. FOCETA project partner RGB Medical Devices S.A. actively participated in MEDICA 2023 Forum with a booth during the whole duration of the event. Within FOCETA, RGB is the leader of the the Medical Use case "Anaesthetic drug Target Control Infusion". At RGB booth, a demonstration video was broadcasted on the research done within the FOCETA project towards the setup of a TestBench platform for the development of the Hollistic Concept of Vital Signs Infusion controller, using Digital Twins and AI (Learning Enabled Components) that mimick at Laboratory Level the Real Life conditions in the Operating Room (including the modelling of the patient's behaviour). Learn more about the final public demonstration video of the FOCETA Medical Use Case, available on the project website: https://lnkd.in/eEx_S-eJ

Metric
Company Name	RGB Medical Devices	Arseus Medical Group	Abiomed, Inc.	Aknamed
Symbol			ABMD
MSH ID	COM:RGB-MEDICAL	BE:ARSEUSMEDICALGROUP	COM:ABIOMED	COM:AKNAMED
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Commercial & Professional Services
Industry	Medical Devices	Medical Supply	Medical - Devices	Healthcare & Health Services
Country	DE	BE	US	IN
Stage
Employee Count			2.00K
Website	rgb-medical.com	arseusmedicalgroup.be	abiomed.com	aknamed.com
LinkedIn	rgb-medical-devices-s-a-
Founders

Metric
Market Cap		17.18B
Enterprise Value
Monthly Web Traffic	46
Web Traffic Growth	0.15
Valuation
Raised Capital

Metric
Revenue			1.03B
Revenue (LTM)
Revenue (NTM)
Gross Profit			843.60M
EBITDA			400.78M
Operating Income			372.69M
Net Income			136.50M
EPS			3
Diluted EPS			2.98
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.82
Operating Profit Margin			0.36
EBITDA Margin			0.39
Net Profit Margin			0.13
Return on Equity			0.10
Return on Assets			0.08
Return on Capital Employed			0.24

COM:RGB-MEDICAL

RGB Medical Devices

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			126.85
P/B Ratio			11.52
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			16.65
EV Multiple			43.20

Metric
Days Sales Outstanding			32.05
Days Payables Outstanding			68.57
Days Inventory Outstanding			182.31
Operating Cycle			214.36
Cash Conversion Cycle			145.80
Asset Turnover			0.62

Metric
Operating Cash Flow			285.39M
Free Cash Flow			249.63M
Cash Flow to Debt
Operating Cash Flow/Sales			0.28
Free Cash Flow Yield			0.01

Metric
Cash & Equivalents			132.82M
Accounts Receivable			5.33M
Inventory			93.98M
Goodwill			76.79M
Debt to Capitalization
Debt to Assets
Current Ratio			7.05
Quick Ratio			6.13

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.05
R&D to Revenue			0.16
SG&A to Revenue